Abstract
Objectives: To establish the clinical effectiveness and cost-effectiveness of structural neuroimaging [structural magnetic resonance imaging (MRI) or computed tomography (CT) scanning] for all patients with psychosis, particularly a first episode of psychosis, relative to the current UK practice of selective screening only where it is clinically indicated.
Original language | English |
---|---|
Pages (from-to) | iii-163 |
Number of pages | 163 |
Journal | Health Technology Assessment |
Volume | 12 |
Issue number | 18 |
DOIs | |
Publication status | Published - 1 May 2008 |